Ardent Health, Inc.
ARDT
$14.56
-$0.02-0.14%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.03% | 8.91% | 10.74% | -- | -- |
| Total Other Revenue | -- | -- | 4.65% | -- | -- |
| Total Revenue | 10.03% | 8.91% | 10.29% | -- | -- |
| Cost of Revenue | 7.35% | 6.52% | 6.32% | -- | -- |
| Gross Profit | 12.07% | 10.75% | 13.42% | -- | -- |
| SG&A Expenses | 5.77% | 6.05% | 7.49% | -- | -- |
| Depreciation & Amortization | 4.89% | 3.99% | 3.87% | -- | -- |
| Other Operating Expenses | 17.40% | 8.63% | 9.85% | -- | -- |
| Total Operating Expenses | 7.49% | 6.44% | 7.06% | -- | -- |
| Operating Income | 60.71% | 62.26% | 87.99% | -- | -- |
| Income Before Tax | 117.27% | 112.47% | 139.46% | -- | -- |
| Income Tax Expenses | 152.68% | 141.27% | 179.86% | -- | -- |
| Earnings from Continuing Operations | 110.45% | 107.10% | 132.37% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -14.39% | -18.73% | -19.04% | -- | -- |
| Net Income | 194.63% | 192.52% | 290.22% | -- | -- |
| EBIT | 60.71% | 62.26% | 87.99% | -- | -- |
| EBITDA | 41.32% | 40.91% | 54.77% | -- | -- |
| EPS Basic | 165.74% | 169.59% | 295.62% | -- | -- |
| Normalized Basic EPS | 200.47% | 266.49% | 689.07% | -- | -- |
| EPS Diluted | 163.27% | 166.82% | 292.73% | -- | -- |
| Normalized Diluted EPS | 198.63% | 265.09% | 686.54% | -- | -- |
| Average Basic Shares Outstanding | 10.53% | 7.70% | 39.92% | -- | -- |
| Average Diluted Shares Outstanding | 11.13% | 8.07% | 40.24% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |